Key indicators: single-crystal X-ray study; T = 113 K; mean (C-C) = 0.002 Å; disorder in main residue; R factor = 0.036; wR factor = 0.092; data-to-parameter ratio = 16.0.
Related literature
For the bioactivity of dihydropyrimidines, see : Brier et al. (2004) ; Cochran et al. (2005) ; Moran et al. (2007) ; Zorkun et al. (2006) . For the bioactivity of organofluorine compounds, see: Hermann et al. (2003) ; Ulrich (2004) . For a related structure, see: Song et al. (2010) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes:
Data collection: CrystalClear (Rigaku, 2009 ); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication: SHELXL97. Comment Dihydropyrimidine (DHPM) derivatives can be used as potential calcium channel blockers (Zorkun et al., 2006) , inhibitors of mitotic kinesin Eg5 for treating cancer (Cochran et al., 2005; Brier et al., 2004) and as TRPA1 modulators for treating pain (Moran et al., 2007) . In addition, compounds that contain fluorine have special bioactivity, e.g. flumioxazin is a widely used herbicide (Hermann et al., 2003; Ulrich, 2004) . This led us to focus our attention on the synthesis and bioactivity of these important fused perfluoroalkylated heterocyclic compounds. During the synthesis of DHPM derivatives, the title compound, an intermediate C 14 H 15 F 3 N 2 O 4 S.C 2 H 5 OH was isolated and the structure confirmed by X-ray diffraction.
In the structure of the title molecule, the 1,3-diazinane ring adopts a half-chair conformation, the mean plane formed by the ring atoms excluding the C atom bonded to the ethoxy carbonyl group has an r.m.s. deviation of 0.0333 Å, the dihedral angle between the mean plane and benzene ring is 56.76 (5) Symmetry codes: (i) −x+1, y−1/2, −z+1/2; (ii) x, y, z−1; (iii) −x+1, −y+1, −z+1; (iv) −x+1, y+1/2, −z+1/2.
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